Liaocheng Jiajie Water Treatment Additive Co., Ltd – Trademark Portfolio
Entity Type: 99
Liaocheng Jiajie Water Treatment Additive Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ACHLOR. The owner is based in Liaocheng City, Shandong Province.
No. 71 Xingyun Street, Chemical Industry Park
Guyun Town, Shen County
Liaocheng City, Shandong Province 252429 , CN
Showing of trademarks Trademarks
Trademark Classifications
Liaocheng Jiajie Water Treatment Additive Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Liaocheng Jiajie Water Treatment Additive Co., Ltd have?
Liaocheng Jiajie Water Treatment Additive Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Liaocheng Jiajie Water Treatment Additive Co., Ltd file in?
Liaocheng Jiajie Water Treatment Additive Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Liaocheng Jiajie Water Treatment Additive Co., Ltd's most well-known trademarks?
Liaocheng Jiajie Water Treatment Additive Co., Ltd's registered trademark portfolio includes well-known marks such as ACHLOR. These are among 1 currently registered trademark in the portfolio.
What is Liaocheng Jiajie Water Treatment Additive Co., Ltd's trademark registration success rate?
Liaocheng Jiajie Water Treatment Additive Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.